<?xml version="1.0" encoding="UTF-8"?>
<fig id="F2" fig-type="figure" orientation="portrait" position="float">
 <label>Fig. 2</label>
 <caption>
  <title>Evaluation of rupintrivir, a PV 3C protease inhibitor.</title>
  <p>(
   <bold>A</bold>) Dose-response analysis. Percentage of single, infected (green, GFP-positive ) cells was determined as a function of rupintrivir concentration. (
   <bold>B</bold> to 
   <bold>F</bold>) Distributions for each parameter in the presence of 10 or 20 nM rupintrivir were compared with that in the absence of drug using a 
   <italic>t</italic> test. A *
   <italic>P</italic> &lt; 0.05 and **
   <italic>P</italic> &lt; 0.005. Numerical values for experimental parameters and statistical analysis are provided in table S2. The parameters presented in the panels are as follows: (B) maximum, (C) slope, (D) infection time, (E) start point, and (F) midpoint. hpi, hours postinfection; a.u., arbitrary units.
  </p>
 </caption>
 <graphic xlink:href="aax4761-F2" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
